Cargando…
Efficacy and safety of 25 and 50 μg desmopressin orally disintegrating tablets in Japanese patients with nocturia due to nocturnal polyuria: Results from two phase 3 studies of a multicenter randomized double‐blind placebo‐controlled parallel‐group development program
This study assessed the efficacy and safety of desmopressin orally disintegrating tablets (ODTs) in Japanese males (50 and 25 μg) and females (25 μg) with nocturia due to nocturnal polyuria (NP). Two Phase 3 randomized double‐blind placebo‐controlled studies of 342 males and 190 females with nocturi...
Autores principales: | Yamaguchi, Osamu, Juul, Kristian V., Falahati, Ali, Yoshimura, Toru, Imura, Futoshi, Kitamura, Mikiya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Asia Pty Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004048/ https://www.ncbi.nlm.nih.gov/pubmed/31397969 http://dx.doi.org/10.1111/luts.12276 |
Ejemplares similares
-
Desmopressin treatment for nocturia caused by nocturnal polyuria: practical guidelines
por: Przydacz, Mikolaj, et al.
Publicado: (2020) -
Desmopressin is an Effective Treatment for Mixed Nocturia with Nocturnal Polyuria and Decreased Nocturnal Bladder Capacity
por: Lee, Hye Won, et al.
Publicado: (2010) -
Impact of Aging on Urinary Natriuretic Peptides in Nocturia and Nocturnal Polyuria
por: Khosla, Lakshay, et al.
Publicado: (2022) -
The Prevalence of Nocturia and Nocturnal Polyuria: Can New Cutoff Values Be Suggested According to Age and Sex?
por: Zumrutbas, Ali Ersin, et al.
Publicado: (2016) -
Assessment of the Most Impactful Combination of Factors Associated with Nocturia and to Define Nocturnal Polyuria by Multivariate Modelling
por: Olesen, Tine, et al.
Publicado: (2020)